Wes Chapman

President, Chapman Strategy & Quality LLC

Wes is currently President of Chapman Strategy & Quality LLC and co-founder of Fortende Health, a company providing advisory services and brokerage in the Medicare insurance sector.

He is a pioneer in the incorporation of advanced quality systems – lean/six sigma and ISO – into medical clinical practice, and an expert in medical quality and value-based care reimbursement systems, teaching these subjects at Dartmouth and Vanderbilt.

Additionally, he has extensive experience in the development of real-world evidence in medical applications and all phases of clinical trials for both drugs and devices. He also has extensive experience bringing new medical devices to market, FDA device approvals and in reimbursement for medical devices.

In collaboration with Dr. Kashyap Patel, President of the Community Oncology Alliance and President of Carolina Blood & Cancer Care Associates, Wes is developing a new oncology clinical trials company focused on recruitment of minority trial participants and addressing equity in the delivery of oncology care.

Previously, Wes co-founded Reimagine Care, an oncology service model company launched with Martin Ventures, a Nashville-based private equity firm. In 2016, he founded and was President and CEO of Verdi Oncology, a medical oncology company dedicated to value-based cancer care.  Wes was also:  an operating partner at Pharos Capital, a private equity group located in Nashville, Tennessee; SVP of Strategy at Tennessee Oncology; Chairman and CEO of M2S, Inc.; and partner at the investment banking firms of Oppenheimer & Co. and Donaldson, Lufkin & Jenrette.

Wes has extensive international experience, running major operations for Japanese investors in North America, and extensive investment and operating experience in South America.

Wes is a graduate of Dartmouth College and the Tuck School of Business at Dartmouth and holds a Lean/Six Sigma Black Belt from the Thayer School of Engineering.